Literature DB >> 19267184

A necrotic skin lesion in a dialysis patient after the initiation of warfarin therapy: a difficult diagnosis.

Marie Antoinette Rockx1, Manish M Sood.   

Abstract

Necrotic skin lesions are unfortunately common in patients with end stage renal disease undergoing dialysis therapy. We present a case of a necrotic skin lesion in a peritoneal dialysis patient shortly after the initiation of warfarin therapy for atrial fibrillation. We discuss and contrast distinguishing features of two diagnostic possibilities: warfarin skin necrosis (WSN) and calcific uremic arteriopathy (CUA) in terms of clinical presentation, risk factors and pathology. Lastly, we outline the importance of establishing a diagnosis as treatment regimens differ substantially.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267184     DOI: 10.1007/s11239-009-0325-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  5 in total

Review 1.  Calciphylaxis: a case study with differential diagnosis.

Authors:  Janice M Beitz
Journal:  Ostomy Wound Manage       Date:  2003-03       Impact factor: 2.629

2.  Warfarin-induced skin necrosis.

Authors:  Stephan Moll
Journal:  Br J Haematol       Date:  2004-09       Impact factor: 6.998

3.  Warfarin-induced skin necrosis and leukocytoclastic vasculitis in a patient with acquired protein C and protein S deficiency.

Authors:  Mevlut Kurt; Ali Shorbagi; Salih Aksu; Ibrahim Haznedaroglu; Kadri Altundag; Gul Erkin
Journal:  Blood Coagul Fibrinolysis       Date:  2007-12       Impact factor: 1.276

4.  Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.

Authors:  Adrian Fine; James Zacharias
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

Review 5.  Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment.

Authors:  William A Wilmer; Cynthia M Magro
Journal:  Semin Dial       Date:  2002 May-Jun       Impact factor: 3.455

  5 in total
  5 in total

1.  Oral anticoagulation with coumarins for patients with atrial fibrillation and chronic kidney disease?

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

Review 2.  [Cutaneous calciphylaxis].

Authors:  U Wollina
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

3.  Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Authors:  Manish M Sood; Maria Larkina; Jyothi R Thumma; Francesca Tentori; Brenda W Gillespie; Shunichi Fukuhara; David C Mendelssohn; Kevin Chan; Patricia de Sequera; Paul Komenda; Claudio Rigatto; Bruce M Robinson
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

4.  Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.

Authors:  Salima Juma; Benjamin K A Thomson; Charmaine E Lok; Catherine M Clase; Peter G Blake; Louise Moist
Journal:  BMC Nephrol       Date:  2013-08-13       Impact factor: 2.388

5.  Warfarin skin necrosis mimicking calciphylaxis in a patient with secondary hyperparathyroidism undergoing peritoneal dialysis.

Authors:  Jee Eun Park; Seonggyu Byeon; Hee Kyung Kim; Seong Mi Moon; Ji Hoon Moon; Kee-Taek Jang; Byung-Jae Lee; Hye Ryoun Jang; Wooseong Huh; Dae Joong Kim; Yoon-Goo Kim; Ha Young Oh; Jung Eun Lee
Journal:  Kidney Res Clin Pract       Date:  2015-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.